A non-invasive hemodynamic monitoring system designed to provide continuous, accurate, and sensitive measurements of cardiac output (CO) and other key hemodynamic parameters.

PhysioFlow® utilizes a proprietary Signal Morphology Impedance Cardiography (SM-ICG™) technology, which enhances the accuracy and reliability of non-invasive cardiac output (CO) measurements compared to standard impedance cardiography (ICG).

• Enhanced Signal Processing: Analyzes waveform morphology for more accurate stroke volume estimation.
• Improved Noise Filtering: Effective in high-motion environments (e.g.,during exercise, in ICUs).
• Better Artifact Rejection: Works in challenging patient populations (e.g.,obesity, emphysema, pulmonary edema).

Performance in Clinical Settings

• Maximal exercise testing (e.g., stress tests, sports physiology, cardiopulmonary rehabilitation).
• Intensive Care Units (ICU) with multiple medical devices and high interference.
• Patients with complex conditions, such as:
  • Obesity (improves signal stability over traditional ICG).
  • Pulmonary edema and emphysema (accounts for changes in lung conductivity).
  • High-intensity physical activity (e.g., elite athletes, clinical exercise studies).

Six Key Benefits of PhysioFlow®

1️⃣ Early Detection of Cardiovascular Abnormalities

• Identifies hemodynamic issues that may go undiagnosed due to limitations of traditional methods (e.g., catheter invasiveness, operator bias in echocardiography, or lack of sensitivity in stress ECG).

2️⃣ Personalized & Precise Treatment

• Provides better insight into cardiovascular conditions (e.g., hypertension, heart failure), allowing for tailored interventions (medication, rehabilitation, pacing).
• Ensures accurate monitoring of treatment outcomes due to its high sensitivity and reproducibility.

3️⃣ Improved Heart Failure Prognosis

• Enhances the prediction of heart failure deterioration after cardiopulmonary exercise testing, outperforming ECG or ECG+VO₂ tests alone.

4️⃣ Enhanced Differential Diagnosis

• Helps determine the cause of exercise intolerance in unclear cases (e.g., dyspnea, post-COVID patients, non-responders to cardiac rehab).

5️⃣ Optimization of Fitness & Performance

• Identifies performance-limiting physiological factors, helping patients optimize training and overall cardiovascular health, reducing mortality and improving quality of life.

6️⃣ Reduction in Invasive Procedures

• Provides a non-invasive alternative for initial cardiovascular evaluations, potentially reducing the need for Swan-Ganz catheterization in pulmonary hypertension assessments.